Cargando…
Global Quality Standard for Identification and Management of Severe Asthma
INTRODUCTION: Severe asthma is a debilitating, life-threatening disease associated with substantial global morbidity, mortality, and health care resource utilization. Patients may not receive guideline-directed medical care for severe asthma. Moreover, viable precision-based assessment tools and new...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444397/ https://www.ncbi.nlm.nih.gov/pubmed/32725419 http://dx.doi.org/10.1007/s12325-020-01450-7 |
_version_ | 1783573798388236288 |
---|---|
author | Haughney, John Winders, Tonya A. Holmes, Steve Chanez, Pascal Saul, Hannah Menzies-Gow, Andrew |
author_facet | Haughney, John Winders, Tonya A. Holmes, Steve Chanez, Pascal Saul, Hannah Menzies-Gow, Andrew |
author_sort | Haughney, John |
collection | PubMed |
description | INTRODUCTION: Severe asthma is a debilitating, life-threatening disease associated with substantial global morbidity, mortality, and health care resource utilization. Patients may not receive guideline-directed medical care for severe asthma. Moreover, viable precision-based assessment tools and newer preventive therapies that can reduce the frequency of exacerbations and associated functional impact are underused. As a result, high rates of poorly controlled severe asthma persist, and patient health-related quality of life suffers. METHODS: In 2019, the Improve Access to Better Care Task Force of the PRECISION Steering Committee set out to develop a global template on quality standards for severe asthma care to support improved access to and delivery of quality care. This Quality Standard is grounded in the vast body of published evidence available for severe asthma care, published clinical guidelines (i.e., from the Global Initiative for Asthma in 2019 and the European Respiratory Society/American Thoracic Society in 2014), and the 2018 PRECISION-supported Charter to Improve Patient Care in Severe Asthma. RESULTS: The Quality Standard developed emphasizes four key elements aimed at optimizing clinical care and outcomes in severe asthma: (1) organization of services, (2) timely identification and referral for suspected severe asthma, (3) specialized assessment and management of severe asthma to optimize outcomes, and (4) patient-centric care and shared decision-making that is reflective of the patient’s expectations, priorities, and values. Four key Quality Statements are provided, along with quality metrics and strategies for local adaptation to optimize implementation. CONCLUSION: This Global Quality Standard is intended to mobilize policymakers, health care providers, and patient advocacy groups to build consensus on the definition and expectations of quality care in severe asthma, to promote patient-centric care, to identify gaps in care and areas for improvement, and systematically implement improvement measures and outcomes and to reduce the burden of illness for patients with severe asthma. |
format | Online Article Text |
id | pubmed-7444397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-74443972020-08-31 Global Quality Standard for Identification and Management of Severe Asthma Haughney, John Winders, Tonya A. Holmes, Steve Chanez, Pascal Saul, Hannah Menzies-Gow, Andrew Adv Ther Commentary INTRODUCTION: Severe asthma is a debilitating, life-threatening disease associated with substantial global morbidity, mortality, and health care resource utilization. Patients may not receive guideline-directed medical care for severe asthma. Moreover, viable precision-based assessment tools and newer preventive therapies that can reduce the frequency of exacerbations and associated functional impact are underused. As a result, high rates of poorly controlled severe asthma persist, and patient health-related quality of life suffers. METHODS: In 2019, the Improve Access to Better Care Task Force of the PRECISION Steering Committee set out to develop a global template on quality standards for severe asthma care to support improved access to and delivery of quality care. This Quality Standard is grounded in the vast body of published evidence available for severe asthma care, published clinical guidelines (i.e., from the Global Initiative for Asthma in 2019 and the European Respiratory Society/American Thoracic Society in 2014), and the 2018 PRECISION-supported Charter to Improve Patient Care in Severe Asthma. RESULTS: The Quality Standard developed emphasizes four key elements aimed at optimizing clinical care and outcomes in severe asthma: (1) organization of services, (2) timely identification and referral for suspected severe asthma, (3) specialized assessment and management of severe asthma to optimize outcomes, and (4) patient-centric care and shared decision-making that is reflective of the patient’s expectations, priorities, and values. Four key Quality Statements are provided, along with quality metrics and strategies for local adaptation to optimize implementation. CONCLUSION: This Global Quality Standard is intended to mobilize policymakers, health care providers, and patient advocacy groups to build consensus on the definition and expectations of quality care in severe asthma, to promote patient-centric care, to identify gaps in care and areas for improvement, and systematically implement improvement measures and outcomes and to reduce the burden of illness for patients with severe asthma. Springer Healthcare 2020-07-28 2020 /pmc/articles/PMC7444397/ /pubmed/32725419 http://dx.doi.org/10.1007/s12325-020-01450-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Commentary Haughney, John Winders, Tonya A. Holmes, Steve Chanez, Pascal Saul, Hannah Menzies-Gow, Andrew Global Quality Standard for Identification and Management of Severe Asthma |
title | Global Quality Standard for Identification and Management of Severe Asthma |
title_full | Global Quality Standard for Identification and Management of Severe Asthma |
title_fullStr | Global Quality Standard for Identification and Management of Severe Asthma |
title_full_unstemmed | Global Quality Standard for Identification and Management of Severe Asthma |
title_short | Global Quality Standard for Identification and Management of Severe Asthma |
title_sort | global quality standard for identification and management of severe asthma |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444397/ https://www.ncbi.nlm.nih.gov/pubmed/32725419 http://dx.doi.org/10.1007/s12325-020-01450-7 |
work_keys_str_mv | AT haughneyjohn globalqualitystandardforidentificationandmanagementofsevereasthma AT winderstonyaa globalqualitystandardforidentificationandmanagementofsevereasthma AT holmessteve globalqualitystandardforidentificationandmanagementofsevereasthma AT chanezpascal globalqualitystandardforidentificationandmanagementofsevereasthma AT saulhannah globalqualitystandardforidentificationandmanagementofsevereasthma AT menziesgowandrew globalqualitystandardforidentificationandmanagementofsevereasthma AT globalqualitystandardforidentificationandmanagementofsevereasthma |